You have likely been following discussions at your institution and in the national press about disclosure and transparency issues in light of the recent resignation of Memorial Sloan Kettering Cancer Center’s Chief Medical Officer, Dr. José Baselga, following a New York Times article about his failure to disclose industry ties in a large number of publications. The attached memorandum discusses some of the background, related AAMC activities, and some immediate steps you can take to communicate with your faculty about this situation and our shared obligation to facilitate the disclosure of timely, accurate, and complete information about academic medicine’s relationships with industry.
This is the beginning of a much larger conversation in which all of you are engaged at your institutions and with the AAMC, and we are grateful for the work of this group. With the assistance of the FOCI Steering Committee leadership and the collaboration of partners across the AAMC membership and broader research community, we will ensure that you are kept informed about new developments and involved in these critical issues.
Ross McKinney, Chief Scientific Officer, and I are always available to you for questions or comments, so do not hesitate to reach out to us or to others in this group.
Heather H. Pierce, JD, MPH
Senior Director, Science Policy
Regulatory Counsel, Scientific Affairs
Association of American Medical Colleges
655 K Street NW, Suite 100
Washington, DC 20001
T: 202-478-9926 E: email@example.com